Adimmune (TPE:4142) Interest Expense: NT$-31 Mil (TTM As of Dec. 2025)

What is Adimmune Interest Expense?

Adimmune TPE:4142 -0.28% 58 Interest Expense is NT$-31 Mil as of Dec. 2025. GuruFocus rates TPE:4142 with a GF Score™ of 58/100 and a GF Value™ of NT$25.60 (Possible Value Trap). The stock has 6 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Adimmune's interest expense for the three months ended in Dec. 2025 was NT$ -10 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2025 was NT$-31 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Adimmune's Operating Income for the three months ended in Dec. 2025 was NT$ 200 Mil. Adimmune's Interest Expense for the three months ended in Dec. 2025 was NT$ -10 Mil. Adimmune's Interest Coverage for the quarter that ended in Dec. 2025 was 19.23. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Adimmune (TPE:4142) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Adimmune's Interest Expense for the three months ended in Dec. 2025 was NT$-10 Mil. Its Operating Income for the three months ended in Dec. 2025 was NT$200 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2025 was NT$1,594 Mil.

Adimmune's Interest Coverage for the quarter that ended in Dec. 2025 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2025 )	/	Interest Expense (Q: Dec. 2025 )
	=	-1	*	199.986	/	-10.399
	=	19.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Adimmune Interest Expense Historical Data

* Premium members only.

The historical data trend for Adimmune's Interest Expense can be seen below:

Adimmune Interest Expense Chart

Adimmune Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Interest Expense

Get a 7-Day Free Trial

-14.69

-22.59

-33.43

-36.49

-31.16

Adimmune Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25
Interest Expense	Get a 7-Day Free Trial															-7.96	-5.52	-6.42	-8.82	-10.40

58GF Score

Adimmune Corp TPE:4142

Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Adimmune Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-31 Mil.

Frequently Asked Questions Learn more about Interest Expense →

What does a Interest Expense of NT$-31 Mil mean?

Adimmune (TPE:4142) has a Interest Expense of NT$-31 Mil as of Dec. 2025. Interest Expense is the amount a company pays on its long-term debt. View historical data on Adimmune and its competitors.

Is Adimmune's Interest Expense too high?

Adimmune's current Interest Expense is NT$-31 Mil. Overall, Adimmune has a GF Score™ of 58/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.

How does Adimmune's Interest Expense compare to VRTX and REGN?

Adimmune's Interest Expense of NT$-31 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Interest Expense for a Biotechnology company?

A good Interest Expense depends on the Biotechnology industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Interest Expense mean?

A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Adimmune and its competitors. Adimmune's current Interest Expense is NT$-31 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Adimmune stock overvalued right now?

Based on GuruFocus' analysis, Adimmune (TPE:4142) is currently considered Possible Value Trap. The stock's GF Value™ is NT$25.60, compared to a current price of NT$17.65 — trading 31.1% below its estimated fair value. The current Interest Expense is NT$-31 Mil. Adimmune's overall GF Score™ is 58/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Interest Expense calculated?

Interest Expense is calculated from a company's financial statements. For Adimmune (TPE:4142), the current Interest Expense is NT$-31 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Adimmune (TPE:4142) Overvalued in 2026?

Based on GuruFocus' analysis, Adimmune stock appears to be undervalued. The current stock price of NT$17.65 is trading 31.1% below its estimated GF Value™ of NT$25.60. GuruFocus considers Adimmune to be Possible Value Trap.

Key valuation signals for TPE:4142:

Interest Expense: NT$-31 Mil
GF Value™: NT$25.60 vs. price of NT$17.65 (31.1% below fair value)
GF Score™: 58/100 with 6 warning signs

No single metric tells the full story. See the TPE:4142 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Adimmune Business Description

Industry Healthcare Biotechnology

Comparable Companies ROCO:6976 ROCO:6617 ROCO:7832 TPE:1734 ROCO:7729 ROCO:7754 ROCO:4167 ROCO:4162 ROCO:4157 ROCO:6610 VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Address Tanxing Road, No. 3, Section 1, Tanzi District, Taichung City, TWN, 427003

Website https://www.adimmune.com.tw

Adimmune Corp is engaged in the research and development, processing, manufacturing, and trading of serum, vaccines, testing reagents, biologicals, and other bacterial fluids, as well as western medicines, animal medicines, chemicals, and feed additives. Its segments are separated by business as Adimmune Corporation, which generates maximum revenue and is engaged in the manufacturing of influenza vaccines with EU GMP and US FDA certificates in Taiwan. Its products include Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine, Influenza A (H1N1) Virus Monovalent Vaccine, and others, and Enimmune Corporation. The Group's revenue is mainly from the manufacturing and trading of vaccines, modern medicine products and testing reagents, as well as entrusted packing of vaccines.

58GF Score

Get the complete analysis for TPE:4142

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$17.65

Price

NT$25.60

GF Value

View TPE:4142 Analysis

See Interest Expense data for all stocks →